Victory Capital Management
TBIO

Victory Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Victory Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,632
Closed -$733K – 2884
2021
Q2 		$733K Buy
+26,632
New +$523K ﹤0.01% 2008
2020
Q2 		– Sell
-14,116
Closed -$140K – 3612
2020
Q1 		$140K Buy
14,116
+5,556
+65% +$45.5K ﹤0.01% 2434
2019
Q4 		$70K Buy
8,560
+3,152
+58% +$29.1K ﹤0.01% 2594
2019
Q3 		$54K Buy
+5,408
New +$51.1K ﹤0.01% 2654

Victory Capital Management's TBIO Position: Q3 2021 in Review

Victory Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 26,632 shares — an estimated $733K sold.

Victory Capital Management first reported a position in TBIO in Q3 2019 and held it in 4 quarters. The position peaked at $733K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Victory Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Victory Capital Management sold 26,632 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $733K.
  • Victory Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's Translate Bio, Inc. Common Stock position peaked at $733K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.